Hikal Ltd, an Indian developer and manufacturer of pharmaceutical and agronomical active ingredients invests US$ 50 Mio in its 3 sites Jigani 1 and Jigani 2 near Bangalore (Karnataka) and Panoli (Gujarat) in 2020 and 2021. The Capex serves to increase contract manufacturing capacity and to add new technologies. Moreover, state-of-the-art finishing systems are added at Hikal’s Panoli, Gujarat, site for API drying, milling and additional space for other technologies.
